Physician profile
Eric M Radzwill
NPI 1861404741
$5,187.86
in general payments reported to CMS, 2019-2025
9 companies · $727 in 2025
The $727 reported for 2025 was more than what 80% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,298 · 2020: $113 · 2021: $630 · 2022: $850 · 2023: $894 · 2024: $676 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,197 · Entertainment: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,196.54 |
| Entertainment | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,900.02 | 2019-2025 | Precision 1, Dailies Total1, Total30 |
| Coopervision INC. | $919.26 | 2019-2025 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $703.22 | 2022-2025 | Miebo, Infuse, Infuse Multifocal |
| Johnson & Johnson Vision Care, INC. | $582.31 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $536.48 | 2019-2021 | |
| Optos, INC. | $300.76 | 2022-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Genentech USA, INC. | $136.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $92.01 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Radzwill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.